N
CALA

Nuveen’s Calithera Biosciences, Inc CALA Stock Holding History

Nuveen’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,200
Closed -$639K – 3615
2021
Q1 		$639K Sell
13,200
-311
-2% -$18.1K ﹤0.01% 3039
2020
Q4 		$1.33M Buy
13,511
+41
+0.3% +$3.59K ﹤0.01% 2695
2020
Q3 		$929K Sell
13,470
-1,908
-12% -$166K ﹤0.01% 2719
2020
Q2 		$1.62M Sell
15,378
-6,893
-31% -$819K ﹤0.01% 2427
2020
Q1 		$1.98M Buy
22,271
+9,843
+79% +$1.17M ﹤0.01% 2194
2019
Q4 		$1.42M Sell
12,428
-16,021
-56% -$1.2M ﹤0.01% 2564
2019
Q3 		$1.76M Buy
28,449
+6,108
+27% +$489K ﹤0.01% 2459
2019
Q2 		$1.74M Buy
+22,341
New +$2.54M ﹤0.01% 2494

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen's CALA Position: Q2 2021 in Review

Nuveen sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 13,200 shares — an estimated $639K sold.

Nuveen first reported a position in CALA in Q2 2019 and held it in 8 quarters. The position peaked at $1.98M in Q1 2020. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Nuveen reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 13,200 Calithera Biosciences, Inc shares in Q2 2021, an estimated $639K.
  • Nuveen first reported a position in Calithera Biosciences, Inc in Q2 2019 and held it in 8 quarters.
  • Nuveen's Calithera Biosciences, Inc position peaked at $1.98M in Q1 2020.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.